RU2016120641A3 - - Google Patents

Download PDF

Info

Publication number
RU2016120641A3
RU2016120641A3 RU2016120641A RU2016120641A RU2016120641A3 RU 2016120641 A3 RU2016120641 A3 RU 2016120641A3 RU 2016120641 A RU2016120641 A RU 2016120641A RU 2016120641 A RU2016120641 A RU 2016120641A RU 2016120641 A3 RU2016120641 A3 RU 2016120641A3
Authority
RU
Russia
Application number
RU2016120641A
Other versions
RU2674604C2 (ru
RU2016120641A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB201318941A external-priority patent/GB201318941D0/en
Priority claimed from GB201410265A external-priority patent/GB201410265D0/en
Application filed filed Critical
Publication of RU2016120641A publication Critical patent/RU2016120641A/ru
Publication of RU2016120641A3 publication Critical patent/RU2016120641A3/ru
Application granted granted Critical
Publication of RU2674604C2 publication Critical patent/RU2674604C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
RU2016120641A 2013-10-28 2014-10-28 Новые полипептиды RU2674604C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB201318941A GB201318941D0 (en) 2013-10-28 2013-10-28 Novel polypeptides
GB1318941.0 2013-10-28
GB201410265A GB201410265D0 (en) 2014-06-10 2014-06-10 Novel polypeptides
GB1410265.1 2014-06-10
PCT/GB2014/053199 WO2015063465A2 (en) 2013-10-28 2014-10-28 Novel polypeptides

Publications (3)

Publication Number Publication Date
RU2016120641A RU2016120641A (ru) 2017-12-05
RU2016120641A3 true RU2016120641A3 (ru) 2018-07-02
RU2674604C2 RU2674604C2 (ru) 2018-12-11

Family

ID=51871092

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016120641A RU2674604C2 (ru) 2013-10-28 2014-10-28 Новые полипептиды

Country Status (12)

Country Link
US (2) US10294274B2 (ru)
EP (1) EP3062823B1 (ru)
JP (3) JP2017502921A (ru)
CN (1) CN105683211B (ru)
AU (2) AU2014343503B2 (ru)
BR (1) BR112016008996B1 (ru)
CA (1) CA2927554C (ru)
ES (1) ES2715379T3 (ru)
NZ (1) NZ719510A (ru)
RU (1) RU2674604C2 (ru)
SG (1) SG11201602889TA (ru)
WO (1) WO2015063465A2 (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2764140T3 (en) 2011-10-07 2017-12-04 Bicyclerd Ltd MODULATION OF STRUCTURED POLYPEPTIME SPECIFICITY
GB201306623D0 (en) 2013-04-11 2013-05-29 Bicycle Therapeutics Ltd Modulation of structured polypeptide specificity
WO2015063465A2 (en) * 2013-10-28 2015-05-07 Bicycle Therapeutics Limited Novel polypeptides
GB201607827D0 (en) 2016-05-04 2016-06-15 Bicycle Therapeutics Ltd Bicyclic peptide-toxin conjugates specific for MT1-MMP
US11730819B2 (en) 2016-12-23 2023-08-22 Bicycletx Limited Peptide derivatives having novel linkage structures
JP7301757B2 (ja) 2017-06-26 2023-07-03 バイスクルアールディー・リミテッド 検出可能部分を持つ二環式ペプチドリガンドおよびその使用
CN107557476A (zh) * 2017-08-25 2018-01-09 华侨大学 一种分析苏云金杆菌制剂对靶虫活性低下原因的方法
JP2020532586A (ja) * 2017-08-31 2020-11-12 シンガポール ヘルス サービシーズ プライベート リミテッド 網膜血管性疾患の処置のためのangio−3
GB201721265D0 (en) 2017-12-19 2018-01-31 Bicyclerd Ltd Bicyclic peptide ligands specific for EphA2
TWI825046B (zh) 2017-12-19 2023-12-11 英商拜西可泰克斯有限公司 Epha2特用之雙環胜肽配位基
GB201810327D0 (en) * 2018-06-22 2018-08-08 Bicycletx Ltd Peptide ligands for binding to IL-17
GB201810316D0 (en) 2018-06-22 2018-08-08 Bicyclerd Ltd Peptide ligands for binding to EphA2
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
JPWO2020230780A1 (ru) * 2019-05-14 2020-11-19
TW202110485A (zh) 2019-07-30 2021-03-16 英商拜西可泰克斯有限公司 異質雙環肽複合物
WO2021198534A1 (en) 2020-04-04 2021-10-07 Oxurion NV Plasma kallikrein inhibitors for use in the treatment of coronaviral disease
JP2023526067A (ja) * 2020-05-15 2023-06-20 バイスクルテクス・リミテッド 抗感染性二環式ペプチドリガンド
WO2023144030A1 (en) 2022-01-31 2023-08-03 Oxurion NV Plasma kallikrein inhibitor therapy for anti-vegf sensitization
WO2023148016A1 (en) 2022-02-04 2023-08-10 Oxurion NV Biomarker for plasma kallikrein inhibitor therapy response

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205527D0 (en) * 2002-03-08 2002-04-24 Ferring Bv Inhibitors
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
NZ560504A (en) 2005-01-24 2009-07-31 Pepscan Systems Bv Binding compounds, immunogenic compounds and peptidomimetics
LT2374472T (lt) 2006-03-16 2018-09-25 Dyax Corp. Kompozicijos ir būdai oftalmologinių sutrikimų gydymui
EP2653544A1 (en) 2008-02-05 2013-10-23 Bicycle Therapeutics Limited Methods and compositions
GB0913775D0 (en) * 2009-08-06 2009-09-16 Medical Res Council Multispecific peptides
JP2013518807A (ja) * 2010-02-04 2013-05-23 メディカル リサーチ カウンシル 多重特異性ペプチド
DK2764140T3 (en) * 2011-10-07 2017-12-04 Bicyclerd Ltd MODULATION OF STRUCTURED POLYPEPTIME SPECIFICITY
GB201117428D0 (en) * 2011-10-07 2011-11-23 Bicycle Therapeutics Ltd Structured polypeptides with sarcosine linkers
US20140274759A1 (en) * 2013-03-15 2014-09-18 Bicycle Therapeutics Limited Modification of polypeptides
GB201306623D0 (en) * 2013-04-11 2013-05-29 Bicycle Therapeutics Ltd Modulation of structured polypeptide specificity
WO2015063465A2 (en) * 2013-10-28 2015-05-07 Bicycle Therapeutics Limited Novel polypeptides

Also Published As

Publication number Publication date
AU2014343503A1 (en) 2016-05-12
CN105683211A (zh) 2016-06-15
BR112016008996B1 (pt) 2023-01-24
JP7170081B2 (ja) 2022-11-11
RU2674604C2 (ru) 2018-12-11
WO2015063465A2 (en) 2015-05-07
US10894808B2 (en) 2021-01-19
ES2715379T3 (es) 2019-06-04
US20190233475A1 (en) 2019-08-01
SG11201602889TA (en) 2016-05-30
EP3062823A2 (en) 2016-09-07
JP2021098755A (ja) 2021-07-01
AU2014343503B2 (en) 2019-01-17
US10294274B2 (en) 2019-05-21
CA2927554A1 (en) 2015-05-07
JP2017502921A (ja) 2017-01-26
BR112016008996A2 (pt) 2017-10-03
AU2019201173B2 (en) 2019-11-21
EP3062823B1 (en) 2018-12-12
CN105683211B (zh) 2020-10-20
NZ719510A (en) 2022-07-01
US20160222063A1 (en) 2016-08-04
JP2019112412A (ja) 2019-07-11
RU2016120641A (ru) 2017-12-05
AU2019201173A1 (en) 2019-03-07
CA2927554C (en) 2022-11-29
WO2015063465A3 (en) 2015-09-11

Similar Documents

Publication Publication Date Title
AP2016009275A0 (ru)
BR112014017733A2 (ru)
BR112014018502A2 (ru)
BR112014017739A2 (ru)
BR112014019326A2 (ru)
BR112014018516A2 (ru)
BR122022020276A2 (ru)
BR112016011691A2 (ru)
BR112016010453A2 (ru)
BR112014020341A2 (ru)
BR112014018480A2 (ru)
BR112014017855A2 (ru)
RU2016120641A3 (ru)
BR112014018468A2 (ru)
BR112014017901A2 (ru)
BR112014018207A2 (ru)
BR112014019204A2 (ru)
BR112014017722A2 (ru)
BR112014018578A2 (ru)
BR112014017794A2 (ru)
BR112016008143A2 (ru)
BR112014018353A2 (ru)
BR112014018496A2 (ru)
BR112014018514A2 (ru)
BR112014017745A2 (ru)

Legal Events

Date Code Title Description
HZ9A Changing address for correspondence with an applicant